Original language | Undefined/Unknown |
---|---|
Pages (from-to) | f113-f114 |
Journal | Circulation |
Volume | 127 |
DOIs | |
Publication status | Published - 2013 |
Spotlight interview Geerten P. van Nieuw Amerongen PhD: Showing That Imatinib Protects Against Endothelial Barrier Dysfunction Via Inhibition of the Tyrosine Kinase Abl-Related Gene.
G.P. van Nieuw Amerongen
Research output: Contribution to journal › Article › Academic